Boston Scientific (BSX) News Today

Boston Scientific Corporation (NYSE: BSX) — shares are trading lower today despite a string of bullish analyst actions and upbeat quarterly results. Recent Q3 beats, multiple price-target raises and heavy call-option buying have driven positive sentiment, but intraday profit-taking, technical signals and a board departure are likely weighing on the stock.

• Positive Sentiment: Multiple brokers are raising targets / reiterating Buy ratings (Truist raised target to $130). Truist Raises Target
• Positive Sentiment: UBS and other firms reiterated Buy ratings and bullish outlooks (UBS maintained Buy). Analyst support and raised targets provide continued buy-side conviction. UBS Maintains Buy
• Positive Sentiment: Leerink/other sell‑side analysts bumped near- and multi‑year EPS forecasts after the quarter, implying stronger forward earnings power. Leerink Raises Estimates
• Positive Sentiment: Q3 results were better than expected and management raised the 2025 sales forecast, driving upside momentum earlier in the session. Earnings Beat & Higher Forecast
• Positive Sentiment: Unusual options activity — heavy call buying indicates speculative bullish positioning and potential near-term upside pressure. High Call Volume
• Neutral Sentiment: Options‑market flow analysis shows elevated interest but mixed signals on expiration strikes and skew — useful for short-term traders, less so for long-term investors. Options Market Analysis
• Neutral Sentiment: Longer-term pieces highlight M&A strategy and organic growth, reinforcing a constructive thesis but not an immediate price catalyst. M&A & Organic Growth
• Negative Sentiment: Board turnover: John E. Sununu will not seek re‑election, a governance change that can create short-term uncertainty. Board Departure
• Negative Sentiment: Technical/market‑structure caution: some coverage notes a “death cross” risk and recent choppy trading that can prompt short-term selling. Technical Warning

Bottom line for investors: fundamentals and analyst revisions are bullish, supported by an earnings beat and stronger forecasts, while short‑term option flows and technical/board developments explain today's pullback. If you own BSX, consider whether this is a buying opportunity given raised estimates and analyst conviction, or a chance to trim on near-term volatility.